Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascilion
Kista, Swedenascilion.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Ascilion has developed a proprietary hollow microneedle array technology enabling painless, rapid, and quantitative sampling of pure dermal interstitial fluid. This allows comprehensive biomarker evaluation from the skin with minimal invasiveness. Their PELSA device/platform supports both research and pharmaceutical/cosmetic testing. Clinical validation studies are ongoing in collaboration with leading European academic hospitals as part of the DIGIPREDICT program to demonstrate utility in heart failure patients and allergy/urticaria models. The company’s products are currently undergoing medical product approval processes.
- Therapeutic areas
- DermatologyImmunologyEndocrinologyCardiovascular
- Modalities
- Device (hollow microneedle array for fluid sampling)Diagnostic device
- Industry
- Physiological Monitoring
02
Partnerships
DIGIPREDICT consortium partners including Charité Berlin hospital, EPFL Switzerland, IMEC-BE/NL institutes
Beyond the preview
Go deeper on Ascilion.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ascilion.